Solar Energy News  
INTERN DAILY
Honey bees could help scientists create new antibiotics
by Brooks Hays
Washington (UPI) Sep 7, 2017


A protein produced by honey bees could inspire the first new antibiotic in 30 years.

Health officials are desperate for new antibiotics as dangerous bacterial strains strengthen their resistance against long-used drugs.

Every year in the United States, 2 million people are infected with drug-resistant bacteria. For 23,000 people, the infection and related complications prove fatal.

Researchers are constantly scanning nature for compounds and molecules that might inspire new antibiotics. Recent studies have identified potential compounds in sponges and Komodo dragons.

In a new study published this week in the journal Nature Structural & Molecular Biology, researchers highlight the promising Api137, a protein capable of blocking protein production in harmful bacteria.

The protein is produced naturally by bees, wasps and hornets, and helps keep the insects infection-free.

Most antibiotics disrupt protein production by targeting the ribosome inside bacterial cells. The ribosome is responsible for synthesizing the proteins that allow bacteria cells to function.

Api137 -- an antibacterial peptide, or small protein -- works by thwarting DNA translation, the genomic process that sees genetic instructions read and translated into fresh proteins.

The latest analysis of Api137 -- carried out by researchers at the University of Illinois at Chicago -- has helped scientists better understand exactly how the protein works. Now, scientists are working to replicate, or synthesize, the peptide in the lab.

"This project was a result of an excellent collaboration of our team," researcher Vázquez-Laslop said in a news release. "We can now harness the knowledge of how Api137 works in order to make new drugs that would kill bad bacteria using a similar mechanism of action."

INTERN DAILY
Lizard venom could yield blood clot treatment breakthrough
Washington (UPI) Aug 8, 2017
Scientists have created a variety of medicines using compounds discovered in the venoms of snakes, frogs, snails, jellyfish and other animals. New research suggests lizard venoms could serve as an untapped source of medicinal compounds. Specifically, scientists at the University of Queensland believe lizard venoms could yield new treatments for blood clots. Research into lizard v ... read more

Related Links
Hospital and Medical News at InternDaily.com


Thanks for being here;
We need your help. The SpaceDaily news network continues to grow but revenues have never been harder to maintain.

With the rise of Ad Blockers, and Facebook - our traditional revenue sources via quality network advertising continues to decline. And unlike so many other news sites, we don't have a paywall - with those annoying usernames and passwords.

Our news coverage takes time and effort to publish 365 days a year.

If you find our news sites informative and useful then please consider becoming a regular supporter or for now make a one off contribution.
SpaceDaily Contributor
$5 Billed Once


credit card or paypal
SpaceDaily Monthly Supporter
$5 Billed Monthly


paypal only


Comment using your Disqus, Facebook, Google or Twitter login.

Share this article via these popular social media networks
del.icio.usdel.icio.us DiggDigg RedditReddit GoogleGoogle

INTERN DAILY
A sweeter way to make green products

How to draw electricity from the bloodstream

Scientists make methanol using air around us

Could switchgrass help China's air quality?

INTERN DAILY
NASA awards SSL new funding for Dragonfly on-orbit assembly program

New Japanese sniffs out smelly feet

Chinese robotics artist makes real-life 'Transformers'

Voice assistants promise a light-fingered future

INTERN DAILY
Kimberly-Clark next U.S. company to draw more on renewables

Finding better wind energy potential with the new European Wind Atlas

UK wind electricity cheaper than nuclear: data

Last of the 67 turbines for a British wind farm installed

INTERN DAILY
VW recalls 4.86 million vehicles in China over airbag concerns

Waymo suit against Uber on road to trial

5,000 'Dieselgate' deaths in Europe per year: study

Rickshaws to jump start India's all-electric drive

INTERN DAILY
Corvus Energy wins contract to provide battery systems for hybrid fishing vessels

Researchers challenge status quo of battery commercialization

More durable, less expensive fuel cells

Stanford professor tests a cooling system that works without electricity

INTERN DAILY
Discovery could reduce nuclear waste by chemically reengineering molecules

Finland's TVO challenges approval of Areva bailout

Russia's use and stockpiles of highly enriched uranium pose significant nuclear risks

EU parliament opposes bid to reduce testing of Fukushima food imports

INTERN DAILY
SLAC-led project will use AI to prevent or minimize electric grid failures

Scientists propose method to improve microgrid stability and reliability

ADB: New finance model needed for low-carbon shift in Asia

China merges energy giants into global leader

INTERN DAILY
Poland accuses EU's top court of bias in primeval forest case

Restored forest now shelters dozens of endangered species

Chocolate industry driving deforestation of Ivory Coast: report

Researchers discover new tree genus in the Andes









The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us.